I predict trials to be completed by early 2023. I’m not adding anymore to my position anymore as I’m already overweight in IBX with my 500K units - yep not fun being down 28% as I’m avg 10c but no big deal.
Patience young grasshoppers... the biggest transfer of wealth in the biotech / imaging space is coming.
Currently at 69 mil market cap = watch us become a billion dollar with the likes of $IMU once results come through and commercialisation is then accelerated. $$$ HUGE addressable market in addition to the various pipeline of products we’re working on... More upside POTENTIAL in the LT than downside.
Now that’s up to you to decide whether it’s worth selling at a loss now or holding until then. Everything that we want to control... e.g. management, faster trials, recruitment, enrolments, incentives, etc ... THATS beyond our control.
What we can control is our vision and conviction (based on DD and research on IBX) which is greater than the market volatility - par for the course of biotech.
IBX Price at posting:
6.8¢ Sentiment: Hold Disclosure: Held
